Traws Pharma’s Executive Surge: Senior Leaders Stack 33,435 Stock Options, Signaling Confidence Ahead of Potential Milestone Rally
Strategic insider stock‑option awards at Traws Pharma signal executive confidence—potential future rally if clinical milestones hit, boosting long‑term investor upside.
2 minutes to read